Celcuity (CELC) News Today $15.14 +0.16 (+1.07%) (As of 09/16/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period Celcuity (NASDAQ:CELC) Sees Large Volume IncreaseCelcuity (NASDAQ:CELC) Sees Unusually-High Trading VolumeSeptember 13 at 2:58 PM | marketbeat.comCelcuity (NASDAQ:CELC) Shares Down 3.5% Celcuity (NASDAQ:CELC) Trading Down 3.5%September 12, 2024 | marketbeat.comCelcuity Inc. (NASDAQ:CELC) Receives Consensus Recommendation of "Buy" from AnalystsSeptember 11, 2024 | americanbankingnews.comCelcuity (CELC) Holds a Potential Game-changer in Cancer TreatmentSeptember 11, 2024 | msn.comShort Interest in Celcuity Inc. (NASDAQ:CELC) Rises By 10.2%Celcuity Inc. (NASDAQ:CELC - Get Free Report) was the target of a large growth in short interest in August. As of August 15th, there was short interest totalling 2,490,000 shares, a growth of 10.2% from the July 31st total of 2,260,000 shares. Based on an average daily trading volume, of 386,900 shares, the short-interest ratio is presently 6.4 days.September 1, 2024 | marketbeat.comLifeSci Capital Initiates Coverage of Celcuity (CELC) with Outperform RecommendationAugust 28, 2024 | msn.comGedatolisib’s Market Potential: A Buy Rating with Optimistic Trial Outcome ProjectionsAugust 22, 2024 | markets.businessinsider.comPI3K Inhibitors Market to Observe Stunning Growth During the Study Period (2020-2034) | DelveInsightAugust 21, 2024 | finance.yahoo.comHennion & Walsh Asset Management Inc. Acquires Shares of 54,217 Celcuity Inc. (NASDAQ:CELC)Hennion & Walsh Asset Management Inc. bought a new position in Celcuity Inc. (NASDAQ:CELC - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 54,217 shares of the company's stock, valued at approAugust 21, 2024 | marketbeat.comCelcuity Inc. (NASDAQ:CELC) Q2 2024 Earnings Call TranscriptAugust 19, 2024 | insidermonkey.comCELC Mar 2025 35.000 call (CELC250321C00035000)August 17, 2024 | finance.yahoo.comCelcuity (NASDAQ:CELC) Posts Quarterly Earnings ResultsCelcuity (NASDAQ:CELC - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.62) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.71) by $0.09. During the same quarter in the prior year, the business posted ($0.66) earnings per share.August 17, 2024 | marketbeat.comBuy Rating Affirmed: Optimism for Celcuity’s Pipeline and Financial Stability Amid Clinical Trial ProgressAugust 17, 2024 | markets.businessinsider.comCelcuity Inc. (NASDAQ:CELC) Receives Consensus Rating of "Buy" from AnalystsCelcuity Inc. (NASDAQ:CELC - Get Free Report) has received a consensus recommendation of "Buy" from the six research firms that are covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendatAugust 17, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Shares Gap Up to $16.33Celcuity (NASDAQ:CELC) Shares Gap Up to $16.33August 15, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: TransCode Therapeutics (RNAZ) and Celcuity (CELC)August 15, 2024 | markets.businessinsider.comCelcuity's (CELC) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $23.00 price target on shares of Celcuity in a report on Thursday.August 15, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Price Target Cut to $39.00 by Analysts at Stifel NicolausStifel Nicolaus dropped their price target on shares of Celcuity from $40.00 to $39.00 and set a "buy" rating on the stock in a research note on Thursday.August 15, 2024 | marketbeat.comOptimistic Outlook for Celcuity’s Gedatolisib in Phase III Trials Supports Buy RatingAugust 15, 2024 | markets.businessinsider.comCelcuity (NASDAQ:CELC) Stock Price Down 4.5%Celcuity (NASDAQ:CELC) Shares Down 4.5%August 14, 2024 | marketbeat.comCelcuity Inc. Reports Second Quarter Financial Results and Provides Corporate UpdateAugust 14, 2024 | globenewswire.comStock Index Futures Tread Water as Key U.S. Inflation Data LoomsAugust 14, 2024 | theglobeandmail.comCelcuity (NASDAQ:CELC) Trading Up 7.9%Celcuity (NASDAQ:CELC) Trading 7.9% HigherAugust 13, 2024 | marketbeat.comCELC Dec 2024 20.000 put (CELC241220P00020000)August 13, 2024 | finance.yahoo.comCELC Mar 2025 20.000 call (CELC250321C00020000)August 13, 2024 | finance.yahoo.comCelcuity (CELC) to Release Earnings on WednesdayCelcuity (NASDAQ:CELC) will be releasing earnings after the market closes on Wednesday, August 14, Zacks reports.August 8, 2024 | marketbeat.comCelcuity Inc CELCAugust 7, 2024 | morningstar.comCelcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference CallAugust 7, 2024 | globenewswire.comCelcuity (NASDAQ:CELC) Shares Gap Down to $17.28Celcuity (NASDAQ:CELC) Shares Gap Down to $17.28August 5, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Makes New $3.55 Million Investment in Celcuity Inc. (NASDAQ:CELC)Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Celcuity Inc. (NASDAQ:CELC - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The fund bought 164,100 shares of the company's stock, valued at approximately $3,545,0July 26, 2024 | marketbeat.comCelcuity Inc. (NASDAQ:CELC) Forecasted to Post Q2 2024 Earnings of ($0.72) Per ShareCelcuity Inc. (NASDAQ:CELC - Free Report) - Equities researchers at Leerink Partnrs issued their Q2 2024 earnings per share (EPS) estimates for shares of Celcuity in a note issued to investors on Monday, July 22nd. Leerink Partnrs analyst A. Berens expects that the company will earn ($0.72) per sJuly 25, 2024 | marketbeat.comLeerink Partners Initiates Coverage of Celcuity (CELC) with Outperform RecommendationJuly 23, 2024 | msn.comCelcuity Inc. (NASDAQ:CELC) Given Consensus Rating of "Buy" by BrokeragesCelcuity Inc. (NASDAQ:CELC - Get Free Report) has been assigned a consensus recommendation of "Buy" from the five brokerages that are currently covering the firm, MarketBeat reports. Five analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have upJuly 23, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Upgraded by Leerink Partnrs to Strong-BuyLeerink Partnrs raised Celcuity to a "strong-buy" rating in a research report on Monday.July 23, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Shares Gap Up to $17.28Celcuity (NASDAQ:CELC) Shares Gap Up to $17.28July 22, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Research Coverage Started at SVB LeerinkSVB Leerink started coverage on Celcuity in a research note on Monday. They issued an "outperform" rating and a $29.00 price target for the company.July 22, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Stock Price Down 3.5%Celcuity (NASDAQ:CELC) Shares Down 3.5%July 16, 2024 | marketbeat.comCelcuity Inc. (NASDAQ:CELC) Sees Large Growth in Short InterestCelcuity Inc. (NASDAQ:CELC - Get Free Report) was the target of a large increase in short interest during the month of June. As of June 30th, there was short interest totalling 2,150,000 shares, an increase of 13.2% from the June 15th total of 1,900,000 shares. Based on an average daily volume of 273,700 shares, the short-interest ratio is currently 7.9 days.July 16, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Trading 0.5% Higher Celcuity (NASDAQ:CELC) Stock Price Up 0.5%July 9, 2024 | marketbeat.comCelcuity: Flying A Phase 3 Trial Right Under Your NoseJuly 5, 2024 | seekingalpha.comPerceptive Advisors LLC Makes New $21.58 Million Investment in Celcuity Inc. (NASDAQ:CELC)Perceptive Advisors LLC bought a new position in shares of Celcuity Inc. (NASDAQ:CELC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,481,300 shares of the company's stock,June 16, 2024 | marketbeat.comCommodore Capital LP Has $25.57 Million Holdings in Celcuity Inc. (NASDAQ:CELC)Commodore Capital LP increased its position in shares of Celcuity Inc. (NASDAQ:CELC - Free Report) by 3.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,754,704 shares of the company's stock after buyiJune 12, 2024 | marketbeat.comCelcuity To Participate in Jefferies Global Healthcare ConferenceJune 3, 2024 | globenewswire.comCelcuity (NASDAQ:CELC) Trading 8.1% Higher Celcuity (NASDAQ:CELC) Stock Price Up 8.1%May 31, 2024 | marketbeat.comCelcuity (NASDAQ:CELC) Shares Gap Up to $14.84Celcuity (NASDAQ:CELC) Shares Gap Up to $14.84May 30, 2024 | marketbeat.comCelcuity Announces Pricing of Underwritten Common Stock OfferingMay 30, 2024 | globenewswire.comCelcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt FinancingMay 30, 2024 | globenewswire.comCelcuity (NASDAQ:CELC) Shares Down 4.6% Celcuity (NASDAQ:CELC) Shares Down 4.6%May 17, 2024 | marketbeat.comHC Wainwright Equities Analysts Decrease Earnings Estimates for Celcuity Inc. (NASDAQ:CELC)Celcuity Inc. (NASDAQ:CELC - Free Report) - Stock analysts at HC Wainwright lowered their FY2028 earnings per share (EPS) estimates for shares of Celcuity in a research note issued to investors on Thursday, May 16th. HC Wainwright analyst S. Ramakanth now expects that the company will post earninMay 17, 2024 | marketbeat.comGrowth Potential Drives Buy Rating for Celcuity Despite Current LossesMay 16, 2024 | markets.businessinsider.com Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late. CELC Media Mentions By Week CELC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CELC News Sentiment▼0.580.68▲Average Medical News Sentiment CELC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CELC Articles This Week▼62▲CELC Articles Average Week Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BrightSpring Health Services News Today Addus HomeCare News Today Veracyte News Today Privia Health Group News Today National HealthCare News Today Fortrea News Today CareDx News Today AdaptHealth News Today agilon health News Today Teladoc Health News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CELC) was last updated on 9/16/2024 by MarketBeat.com Staff From Our Partners44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredGrab this ETF paying a huge 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....Investors Alley | SponsoredWhy Institutions Are Bullish on BitcoinThe recent dip in the crypto market might be stressful… But it also presents a tremendous opportunity for s...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.